| Literature DB >> 27268086 |
Hao Jin1, Zhibin Huang2, Yali Chi2, Mei Wu2, Riyang Zhou2, Lingfeng Zhao2, Jin Xu1, Fenghua Zhen1, Yahui Lan1, Li Li3, Wenqing Zhang2, Zilong Wen1, Yiyue Zhang2.
Abstract
Neutrophils are the key effectors for generating innate immunity in response to pathogenic infection and tissue injury in vertebrates. Dysregulation of neutrophil development and function is known to associate with various human disorders. Yet, the genetic network that orchestrates lineage commitment, differentiation, and maturation of neutrophils remains incompletely defined. Here, we present an in vivo study to delineate the genetic program underlying neutrophil development during zebrafish embryonic myelopoiesis. We show that loss of c-Myb function has no effect on macrophages but severely impairs neutrophil terminal differentiation, resulting in the accumulation of neutrophils with unsegmented nuclei and scant granule. This neutrophilic defect, which resembles the neutrophil-specific granule deficiency (SGD) caused by the mutations in CCAAT/enhancer-binding protein ε (C/EBPε) in humans, is attributed, at least in part, to the downregulation of the granule protein transcription. Likewise, genetic inactivation of Cebp1, the zebrafish functional homolog of mammalian C/EBPε, also leads to a similar SGD-like phenotype in zebrafish. Genetic epistasis and biochemical analysis further reveals that c-Myb and Cebp1 act in parallel and cooperatively to control neutrophil differentiation by directly regulating granule protein gene transcription. Our study indicates that c-MYB is an intrinsic master regulator for neutrophil terminal differentiation and a potential target in SGD patients.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27268086 DOI: 10.1182/blood-2015-12-686147
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113